TANDEM(R) E CEA IMMUNORADIOMETRIC ASSAY

FDA Premarket Approval P840019 S012

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Modifications to the hybritech tandem-e cea assay whith enhancements in the formualtion of the alkaline phosphatase-labeled anti-cea antibody conjugate and the addtion of the blocking reagent poly mak 33, a copolymer of intact and fab fragmented mouse anti-human ck-mm antibodies

DeviceTANDEM(R) E CEA IMMUNORADIOMETRIC ASSAY
Generic NameSystem, Test, Carcinoembryonic Antigen
ApplicantHYBRITECH, INC.
Date Received1995-09-21
Decision Date1996-03-07
PMAP840019
SupplementS012
Product CodeDHX 
Advisory CommitteeImmunology
Supplement TypeNormal 180 Day Track
Supplement ReasonChange Design/components/specifications/material
Expedited ReviewNo
Combination Product No
Applicant Address HYBRITECH, INC. 11095 Torreyana Rd. p.o. Box 269006 san Diego, CA 92126

Supplemental Filings

Supplement NumberDateSupplement Type
P840019Original Filing
S012 1995-09-21 Normal 180 Day Track
S011 1992-11-25 Normal 180 Day Track
S010 1991-09-05 Normal 180 Day Track
S009 1990-03-14 Normal 180 Day Track
S008 1989-11-09 Normal 180 Day Track
S007 1989-08-18 Normal 180 Day Track
S006 1987-02-09 Normal 180 Day Track
S005 1986-09-17 Normal 180 Day Track
S004 1986-03-20 Normal 180 Day Track
S003 1985-08-23
S002 1985-03-29
S001 1984-08-01

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.